Treatment.com AI Stock Price, News & Analysis

Rocket Doctor (TREIF) announced contracts and credentialing with six major U.S. insurers across Medicare Advantage, Medicaid Managed Care and Commercial plans, covering an estimated more than 7 million members in California and New York as of October 8, 2025.

The agreements make Rocket Doctor’s physician-led, AI-powered digital health platform in-network for those members, supporting urgent care, primary care, mental health, chronic disease management, preventive services and prescription support. The company highlighted HIPAA-compliant telehealth, integration of connected devices and proprietary AI, and cited a track record of over 700,000 patient visits delivered across North America.

Rocket Doctor (TREIF) announces a delay in mailing its proxy circular and related documents for the Annual General Meeting due to the Canada Postal Strike. The Meeting is scheduled for Wednesday, October 22, 2025 at 10:00 a.m. PT at McMillan LLP, Suite 1500 – 1055 West Georgia Street, Vancouver, BC.

Documents are available on Sedar+ under the company's profile and shareholders may request materials or register proxy votes by contacting kelly.pladson@rocketdoctor.ai. The proxy voting cutoff is 10:00 a.m. PT on Monday, October 20, 2025.

Rocket Doctor AI (CSE: AIDR) has announced a strategic partnership with Remmie Inc. to distribute the FDA-approved and Health Canada-cleared Remmie 4 smart otoscope in Canada. The device enables patients to perform at-home ear, mouth, and nose examinations, sharing high-quality visuals directly with physicians on the Rocket Doctor platform.

Through this reseller agreement, customers will receive a 20% discount on Remmie 4 devices using unique Rocket Doctor codes. The partnership aims to enhance virtual care capabilities, with Rocket Doctor already serving over 700,000 patients through its network of 300+ MDs. The company is also exploring U.S. expansion opportunities for the Remmie program.

Rocket Doctor AI (CSE: AIDR) announced its participation in the upcoming CANTech Letter Investment Conference on October 9, 2025, in Toronto, Ontario. CEO Dr. Essam Hamza and Rocket Doctor Inc. Founder Dr. William Cherniak will present at 2:30 PM ET in Track 1.

The presentation will showcase the company's healthcare technology platform, which focuses on AI-powered solutions for improving healthcare accessibility. The executives will discuss platform innovations, recent milestones, and growth strategy during their 30-minute session.

Rocket Doctor AI (CSE: AIDR) has announced the automatic conversion of 3,677,400 special warrants into common shares and warrants. The company filed a prospectus supplement on September 22, 2025, qualifying the distribution of securities in British Columbia, Alberta, and Ontario.

Each warrant allows holders to purchase one common share at $0.75 per share for 12 months from issuance. The special warrants will automatically convert on October 2, 2025, with no action required from holders. The securities are not registered under U.S. securities law and cannot be offered or sold in the United States without registration or exemption.

Rocket Doctor AI Inc. (CSE: AIDR) has announced that its digital health platform is now in-network with Maryland Medicaid and Medicare, significantly expanding healthcare access for over 2.6 million eligible residents. The platform will provide virtual care services including urgent care, chronic disease management, preventive health, and mental health care.

This development particularly benefits rural and underserved communities, serving approximately 25% of Maryland's population through Medicaid (1.52 million people) and 17% through Medicare (1.14 million people). The in-network status reduces out-of-pocket costs and aligns with Maryland's AHEAD Model, focusing on expanding access, advancing equity, and reducing healthcare costs.

Rocket Doctor AI (CSE: AIDR) has announced a groundbreaking partnership with the Town of Bruderheim, Alberta, marking its first municipal collaboration to expand virtual healthcare access. The partnership, launching September 15, 2025, will provide Bruderheim residents with access to physician-led, AI-powered digital healthcare services fully covered by Alberta Health.

The platform has demonstrated significant growth in Alberta, serving over 71,000 Albertans, with 35% from rural communities. In the past year, the company achieved a 112% increase in patient visits to 36,779 and a 218% growth in physician participation. The partnership will automatically renew on July 10th, 2026, offering services including urgent care, chronic disease management, and preventive health care.

Rocket Doctor AI (CSE: AIDR) has expanded its pharmacy-based virtual care program to 50 independent pharmacies across Canada. The program integrates physician-led, AI-powered virtual care directly into pharmacies, particularly in rural and underserved areas.

The platform has facilitated over 16,500 appointments, with 75% resulting in prescriptions, of which 99% were filled at the originating pharmacy. The service includes urgent care, family medicine, and specialist services covered by provincial insurance. In Stony Plain, Alberta, one pharmacy completed 530 appointments, resulting in 424 prescriptions.

The company has also expanded to the United States, implementing virtual health kiosks in 3 housing complexes in inner-city New York, with plans to partner with Federally Qualified Health Centers (FQHCs).

Rocket Doctor AI (CSE: AIDR, OTC: AIRDF) announced that its digital health platform is now in-network with Aetna in New York State for both Medicare and commercial insurance plans. This credentialing enables Aetna's members to access Rocket Doctor's virtual healthcare services with reduced out-of-pocket costs.

The company's platform offers urgent care, chronic disease management, preventive and mental health services. Rocket Doctor is already operating in New York through partnerships with EngageWell IPA and the CVS Health Foundation's Healthy Aging Program, which received $1 million in funding to provide free virtual health screenings for adults over 60.

Additionally, the company granted 64,896 RSUs and 16,224 stock options to a consultant, with options exercisable at C$0.67 per share over a three-year period.